FindTrial
Sign In

Research on the Construction of a Biological Mechanism Diagnostic Model for Breast Cancer Liver Depression Syndrome Based on Transcriptomics and Deep Learning

Research on the Construction of a Biological Mechanism Diagnostic Model for Breast Cancer Liver Depression Syndrome Based on Transcriptomics and Deep Learning

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000645
Enrollment
Unknown
Registered
2025-04-02
Start date
2025-04-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Breast cancer patients with liver depression syndrome:Liver-Soothing and Depression-Relieving Optimized Formula.
Breast cancer patients with liver depression syndrome and non-liver depression syndrome groups:None

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Subjects must be female patients newly diagnosed with breast cancer; 2.Aged between 18 and 65 years; 3.Voluntarily participate in the trial demonstrate compliance capability and have provided signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with concurrent other malignant tumors; 2. Patients with concomitant diseases of other systems such as respiratory cardiovascular endocrine urinary systems and mental disorders; 3. Women who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Transcriptomics data;—

Countries

China

Contacts

Public ContactQianqian Guo

Guangdong Provincial Hospital of Chinese Medicine

guoqianqian@gzucm.edu.cn15915740853

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026